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Culture and growth conditions
Unless noted otherwise, chemicals and reagents were purchased from Thermo Fisher Scientific and Sigma-Aldrich ® . Where indicated and unless stated otherwise, antibiotics were used at the following concentrations: kanamycin (Km) 50 μg mL -1 , chloramphenicol (Cm) 25 μg mL -1 , streptomycin (Sm) 500 μg mL -1 , and tetracycline (Tc) 20 μg mL -1 . E. coli strains were grown at 37˚ C in NZY media ( Table S4 for all strains used in this study.
Identification and genomic analysis of CYP115 and core GA operon in rhizobia
In plant pathogens containing the GA biosynthetic operon, CYP115 is always found tightly appended to the 5' end of the operon, and could thus be hypothesized to act in GA biosynthesis in these organisms. The presence of CYP115 in 20 rhizobial strains (Table S1 ) was found through protein BLAST searches on NCBI (https://blast.ncbi.nlm.nih.gov/blast/Blast.cgi) and the Joint Genome Institute (JGI; https://img.jgi.doe.gov/cgi-bin/mer/main.cgi?section=FindGenesBlast&page=gene SearchBlast) using the amino acid sequence of CYP115 from Xanthomonas oryzae pv. oryzicola BLS256, which contains the GA operon. The legumes from which these strains were isolated are listed as found at JGI and/or within the BioSample webpage for each strain on NCBI (Table S1 ). CYP115 and CYP112 pseudo-genes and fragments were further identified by using DNA BLAST searches with the NCBI/GenBank and JGI databases. CYP115 fragments were characterized as being ≥17 base-pairs (bp) in length with nearly 100% identity, in addition to being located within 50 bp of the start codon for CYP112 of the core GA biosynthetic operon. The average length of these fragments (with standard deviation) from 116 rhizobia is 158 ± 130 bp.
The total number of rhizobia with core GA biosynthetic operons (123) was estimated by comparing strains confirmed by BLAST searches to have CPS, KS, CYP117, CYP114 and CYP112 within the JGI database. This number is likely an underrepresentation as it excludes sequences from NCBI/GenBank (and other databases) that may not be available in JGI. Additionally, the confirmation of a full operon relies upon genomic scaffolds in which not only the presence, but also clustering, of operon genes can be observed. As many strains containing GA operon genes do not have well-assembled genomes, this results in many strains being omitted from this analysis.
The location of CYP115 in relation to the core GA operon (Table S2 ) was determined manually by using the graphic genome browser on NCBI. Briefly, CYP115 and the core operon were located via BLAST searches on NCBI, and DNA coordinates were used to calculate the distance between CYP115 genes and the closest gene of the GA operon. For many rhizobial strains with CYP115, this was not possible, as fully assembled genomes were not available, and CYP115 and the GA operon were sometimes located on separate contigs. Insertion sequence (IS) elements near CYP115 genes (Table S3) were located and analyzed manually with the graphic genome browser on NCBI by searching the genomic content in direct proximity to CYP115. Each identified IS element was further categorized and annotated based upon the conserved domains found by using the Conserved Domains tool on NCBI (https://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi).
CYP115 expression constructs
CYP115 expression constructs were created similarly to those used in previous study of the GA biosynthetic operon from S. fredii NGR234. 2 For expression of CYP115 from S. meliloti WSM4191 (SmCYP115), a clone was synthesized using GeneArt TM Gene Synthesis (Thermo Fisher Scientific). Included on the 3' of this clone was the intergenic region following CYP114 from S. fredii NGR234, along with the S. fredii NGR234 Fd GA , which follows this intergenic region. Fd GA has been shown to be necessary for full CYP114 functionality in GA biosynthesis, 2 and was included as it could be a potential redox partner for CYP115. The synthetic clone also contained a 5' leader sequence that contained a ribosome binding site, in addition to several upstream stop codons, as previously described. 2 This clone was amplified from the synthetic gene-containing plasmid (pMK-SmCYP115-Fd GA ) using primers specific to the 5' leader sequence and the 3'end of this dual gene fragment (see Table S5 for a list of all primers used). Additionally, a construct without Fd GA was amplified, using a reverse primer that anneals to the 3' end of SmCYP115. These primers contained restriction sites (BamHI for the forward primer, EcoRI for the reverse primer) allowing for subsequent digestion and ligation into the expression plasmid, pstb-LAFR5 (Tc R ), which has been previously shown to be useful for heterologous expression in S. meliloti 1021 3 , and particularly for the genes found in the GA biosynthetic operon. 2 Notably, S. meliloti 1021 contains neither the GA biosynthetic operon, nor a homolog of CYP115. 4 This construct and the pstb-LAFR5 plasmid were digested using BamHI and EcoRI restriction enzymes (New England Biolabs ® Inc.). The digested SmCYP115 and SmCYP115-Fd GA clones were run on a 1% agarose gel and purified using the GenElute CYP115 from Mesorhizobium loti MAFF303099 (MlCYP115) was cloned directly from genomic DNA, which was previously purified using Wizard ® SV Genomic DNA Purification Kit (Promega). Analysis of CYP115 revealed several potential open reading frames (ORF) of similar length (~1200-1300 bp) and in the same reading frame. The longest predicted ORF of MlCYP115 (1278 bp; MlCYP115) was PCR amplified using forward and reverse primers specific to the 5' and 3' ends of this ORF (Table S5) , and this construct was ligated into pCR TM -Blunt II-TOPO ® (Thermo Fisher Scientific). In a subsequent PCR reaction, the 5' leader sequence, along with a BamHI restriction site for cloning into pstb-LAFR5, was added to the 5' end via the forward primer and a 3' EcoRI restriction site was added via the reverse primer. This MlCYP115 construct was digested and ligated into pstb-LAFR5 in the same fashion as described for SmCYP115. Though functional activity was found with this clone, sequence alignment with other predicted CYP115 proteins ( Figure S6 ) and the presence of a canonical Shine-Dalgarno sequence suggests that the native ORF is 1233 bp (410 amino acids). This shorter coding sequence was subsequently cloned and expressed, but exhibited indistinguishable activity from the longer clone.
Triparental mating to transfer constructs into S. meliloti 1021
The pstb-LAFR5-CYP115 constructs and an empty pstb-LAFR5 vector were transformed into chemically competent E. coli MM294A "donor" cells 5 and selected on LB agar plates containing Tc (20 μg mL -1 ). Individual colonies were picked for growth in 5 mL NZY media cultures supplemented with Tc. Additionally, 5 mL cultures of E. coli MT616 "helper" cells 6 (Cm R ) were grown in NZY media, and 5 mL cultures of S. meliloti 1021 "recipient" cells (Sm R ) were grown in LB-MC media. All cultures were grown to late log phase, at which point 1 mL of each cultures was centrifuged at 5000 x g for 5 minutes to pellet the cells. The pellets were then washed with 1 mL of sterile 0.85% (w/v) NaCl in water, and centrifuged again. Pellets of the donor, helper, and recipient cells were resuspended in 50 μL of 0.85% NaCl, mixed in equal proportion, and 10-30 μL of this mixture was plated on non-selective LB-MC agar plates. Matings were incubated for 1-2 days, after which the spots were picked and resuspended in 1 mL of 0.85% NaCl.
Serial dilutions of this resuspension were then plated on LB-MC agar containing Sm (for selection of the S. meliloti 1021 recipient) and Tc (for selection of pstb-LAFR5 constructs). Colonies were screened by PCR using primers specific to the construct of interest, or in the case of the empty vector, primers specific to the region upstream of the multiple cloning site.
CYP115 heterologous expression in S. meliloti 1021
Incubations with wild-type (untransformed) strains of S. meliloti 1021 and heterologous strains expressing either an empty vector or pstb-LAFR5-CYP115 constructs were performed in a similar fashion to previous characterization of the GA biosynthetic operon. 2 Briefly, individual colonies were used to inoculate 5 mL LB-MC cultures containing appropriate antibiotics (Sm for S. meliloti 1021 wild-type and Sm + Tc for heterologous strains), and these cultures were shaken at 225 RPM at 30 ˚C until reaching late log phase (1-2 days). For initial experiments, 500 μL of each culture was used to inoculate 50 mL LB-MC cultures containing 5 mL phosphate buffer (pH 7) and the appropriate antibiotic(s). Cultures were grown at 30 ˚C with 225 RPM shaking until they reached early log phase (OD600 0.4-0.7), at which point substrate (5 μM), riboflavin (1 mM; for enhanced redox metabolism), δ-aminolevulinic acid (1 mM; to enhance heme synthesis for incorporation into the recombinant CYP), and FeCl 3 (0.1 mM; also for incorporation into heme of the expressed CYP) were added. GAs were purchased commercially from OlChemIm Ltd. (GA 9 , GA 20 , GA 4 , and GA 1 ), or generously provided by Professor Peter Hedden (Rothamsted Research, Harpenden, U.K.; GA 9 ). Cultures were incubated at 30 ˚C with 225 RPM shaking for 3-5 days. Once the GA3ox functionality of CYP115 was observed, subsequent experiments were run with 10 mL cultures with the added supplements adjusted proportionally. To quantify relative levels of turnover of GA 9 to GA 4 , incubations were run as described above in triplicate for heterologous cells expressing pstb-LAFR5 empty vector, pstb-LAFR5-SmCYP115, pstb-LAFR5-SmCYP115-Fd GA , or pstb-LAFR5-MlCYP115.
Metabolite extraction, purification, and GC-MS analysis
After incubations, cultures were acidified to pH 3 with 5 M HCl to neutralize the free carboxylic acids found in many of the GA metabolites of interest here. Cultures were then extracted 3 times with an equivalent volume of ethyl acetate. These extracts were combined in a round bottom flask and dried with a rotary evaporator. The dried flask was extracted three times with 3 mL of ethyl acetate which was combined in glass tubes and dried under a gentle stream of N 2 . The dried metabolites in each tube were resuspended in 1 mL hexanes for purification over a silica gel column (~1 mL). The 1 mL aliquots were loaded to the silica column and eluted with solutions of hexanes:ethyl acetate (v/v), starting with 100% hexanes and increasing polarity incrementally (by 10-15%) to 100% ethyl acetate with separate fractions collected for each elution solution. Purified fractions were dried under N 2 and resuspended in 500 μL ethyl acetate, after which diazomethane was added to produce the methyl esters of any free carboxylic acids, and this solution was incubated at room temperature for several hours. The methylated fractions were then dried under a gentle stream of N 2 and resuspended in BSTFA+TMCS [N,OBis(trimethylsilyl)trifluoroacetamide + Trimethylchlorosilane; 99:1 v/v] or MSTFA [N-Methyl-N-(trimethylsilyl)trifluoroacetamide] for 30 min at 80 ˚C to produce the trimethylsilyl ethers of any free hydroxyl groups. Samples were then dried down under a gentle stream of N 2 and resuspended in n-hexane for analysis with gas chromatography-mass spectrometry (GC-MS) using a 3900 Saturn GC with Saturn 2100T ion trap MS (Varian) equipped with an HP-5MS column (Agilent). For this analysis, 1 μL of each sample was injected in splitless mode with a column flow of 1.2 mL min -1 at an initial injector temperature of 250 ˚C and a column temperature of 50 ˚C, which was held for 3 minutes. The column temperature was increased to 300 ˚C at a rate of 15 ˚C min -1 , and this temperature (300 ˚C) was held for 3 minutes. Mass spectra acquisition using electron ionization with a collection range of 90 m/z to 650 m/z began at 13 minutes and continued until the end of the run. For optimal peak resolution, publication quality GC-MS runs were performed with a column temperature increase of 10˚ C min -1 and a mass range of 90-550 m/z. GA 4 (2) and GA 1 products were identified via comparison to an authentic standard and to published mass spectral data. 7 For relative quantification of samples run in triplicate, chromatograms were extracted with the 270 and 284 mass-to-charge ions (m/z 270 to distinguish GA 9 and m/z 284 to distinguish GA 4 ), with GA 9 and GA 4 peak areas being integrated manually within the Varian GC-MS software. Relative turnover was calculated by dividing the area of the GA 4 peak by the combined areas of the GA 9 and GA 4 peaks and multiplying this by 100 to give percent turnover. Student's t-test (two sample, assuming equal variance) was performed in Microsoft Excel to determine any statistically significant differences between the tested samples.
CYP115 and GA operon sequence analysis
The identity between CYP115 nucleotide and protein sequences were calculated using the tools available on the European Molecular Biology Laboratory-European Bioinformatics Institute (EMBL-EBI) website. For nucleotide sequences, the MUSCLE program (default parameters) was used, while for proteins the Needle EMBOSS pairwise alignment tool (default parameters) was utilized with the M. loti MAFF303099 CYP115 compared to each rhizobial CYP115 (Table S1 ).
Phylogenetic trees were created in MEGA7. 8 Nucleotide alignments were performed using the MUSCLE algorithm with the GA operon orthologs from X. oryzae pv. oryzicola BLS256 as the outgroup sequences for CYP115 and core GA biosynthetic operon alignments, while the Azotobacter vinelandii DJ nifK sequence was used as the outgroup in the nifK alignment. The trees shown in were created via the Maximum-Likelihood statistical method using the highest ranked substitution model (as determined within MEGA7 for each alignment) with complete deletion and 1000 bootstrap analyses. To verify the observed phylogeny of CYP115 from Mesorhizobium sp. AA22 as closest to the ancestral node among the rhizobia, trees were also calculated using the Neighbor-Joining and Minimum evolution methods ( Figure S4 ). The resulting trees are essentially congruent with that shown for the MaximumLikelihood tree in Figure 3 , including the placement of CYP115 from Mesorhizobium. sp. AA22.
For the phylogenetic trees generated from alignments with CPS and CYP114 from the GA operon, initial trees that included all strains of rhizobia with the core GA biosynthetic operon were created via the Maximum-Likelihood statistical method using the highest ranked substitutional model with complete deletion and 1000 bootstrap analyses ( Figure S5) . Inspection of these trees showed redundancy and very high similarity among certain clusters of sequences (i.e. no observable branch length). Accordingly, these clusters were condensed to individual sequences and the analysis repeated with this reduced set of sequences to present the representative tree shown in Figure 4 . Figure S1 . CYP115 converts GA20 into bioactive GA1. a) When incubated in cells expressing SmCYP115, GA20 is converted into a compound corresponding to GA1 as shown here through GC-MS chromatograms. b) Zoom-in on putative GA1, as indicated by the dotted box from the first panel. c) Mass spectrum of the putative GA1 product. d) Mass spectrum of an authentic GA1 standard. e) Reaction catalyzed by SmCYP115, which corresponds to a C-3β hydroxylation of GA20 to form GA1, a bioactive GA. Chromatograms and mass spectra are representative of compounds derivatized to methyl esters and/or trimethylsilyl ethers. , showing that CYP115 length and sequence is highly similar between these distant lineages. Red highlights with white text indicates strict identity, red characters indicate similarity in a group, and a blue outline represents similarity across groups. The visualization of this alignment was created using ESPript 3.0. 
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